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Abstract
Inorganic polyphosphate (polyP) is a simple ancient polymer of linear chains of 
orthophosphate residues linked by high energy phospho-anhydride bonds ubiqui-
tously found in all organisms. Despite its structural simplicity, it plays diverse func-
tional roles. polyP is involved in myriad of processes including serving as microbial 
phosphagens, buffer against alkalis, Ca2+ storage, metal-chelating agents, pathogen 
virulence, cell viability and proliferation, structural component and chemical 
chaperones, and in the microbial stress response. In mammalian cells, polyP has 
been implicated in blood coagulation, inflammation, bone differentiation, cell 
bioenergetics, signal transduction, Ca2+-signaling, neuronal excitability, as a 
protein-stabilizing scaffold, and in wound healing, among others. This chapter will 
discuss (1) polyP metabolism and roles of polyP in prokaryotic and eukaryotic cells, 
(2) the contribution of polyP to survival, cell proliferation, and motility involved 
in wound healing in human skin keratinocytes, (3) the use of polyP-containing 
platelet-rich plasma (PRP) to promote wound healing in acute and chronic wounds, 
including burns, and (4) the use of polyP-containing PRP in excisional wound 
models to promote faster healing. While polyP shows promise as a therapeutic agent 
to accelerate healing for acute and chronic wounds, the molecular mechanisms as a 
potent modulator of the wound healing process remain to be elucidated.
Keywords: inorganic polyphosphate, wound healing, keratinocytes, platelet-rich 
plasma
1. Introduction
PolyP is a simple prebiotic molecule that varies in chain length between three 
and several thousand inorganic phosphates linked by phosphoanhydride bonds 
(Figure 1A). It is continuously synthesized from ATP or GTP and degraded by cel-
lular enzymes in bacteria [1–5] and eukaryotes, yet its pleiotropic functions remain 
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to be clarified. In bacteria, but not mammalian cells, the enzymes that catalyze 
these activities have been identified [6–10]. polyP is synthesized following osmotic, 
oxidative, UVB, or other cellular stresses, and augments bacterial survival [11–16]; 
four roles have been proposed: an energy source, chelation of metal ions, storage 
of phosphate and response to cellular stresses. Necessary for bacterial survival, 
polyP is implicated in essential biological processes in prokaryotes including stress 
response, motility, biofilm formation [17–22], virulence, sporulation, and quorum-
sensing [21–23]. Enzymes involved in polyP synthesis and degradation have been 
isolated and characterized in bacteria and other lower eukaryotes, and maintain 
tight control of polyP levels, as might be expected for a polymer controlling vital 
biological processes.
1.1 PolyP in prokaryotes
Drawing from the cellular ATP pool, bacterial polyphosphate kinase (PPK1) 
catalyzes the reversible transfer of the terminal γ-phosphate of ATP to polyP 
[24], whereas PPK2, expressed in other prokaryotes, transfers the terminal inor-
ganic phosphate (Pi) from polyP to GDP to form GTP [4, 25, 26]. In contrast, 
the exopolyphosphatase PPX1 hydrolyzes polyP into phosphate monomers, thus 
maintaining phosphate homeostasis [5]. PPK levels and activity are tightly regu-
lated, maintaining steady-state polyP concentrations in the bacterial cytosol at low 
micromolar levels, even in mutant strains deficient in PPX [27]. PolyP synthesis is 
Figure 1. 
(A) Schematic of linear structure of polyP, and its synthesis by polyphosphate kinase (PPK) and degradation 
by exopolyphosphatases (PPX1) or endopolyphosphatases (PPN). Constitutive (B and D) or Tet-inducible 
PPX1 (C and E) expression slows wound healing in cultured human keratinocytes (modified with permission 
from [33]).
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upregulated during nutrient deprivation [28, 29], or during osmotic [28], acidic pH 
[30], oxidative [31], or heat [32] stresses, potentially depleting cellular ATP pools 
by converting millimolar levels of ATP to long polyP chains (>1000 Pi) [31]. polyP 
levels are measured using enzyme-based assays that employ ppk to generate ATP 
from ADP, using luciferase as a reporter [33]. In another assay, cells are labeled with 
32Pi; polyP is isolated and hydrolyzed with PPX1, and thin-layer chromatography or 
phosphoimage analysis is performed [17]. Toluidine blue binding assays are effec-
tive for different chain-lengths but are relatively insensitive. Recently, a rapid and 
simple method has been described [34, 35].31P-NMR Spectroscopy is an effective 
and accurate method for measuring polyP in intact cells [36]. Electron ionization 
mass spectrometry [37], cryoelectron tomography and spectroscopy imaging [38] 
have also been employed. Protein affinity labeling in vivo uses the affinity of a 
recombinant polyP-binding domain of E. coli PPX1 (PPXbd) [39], which we and 
other investigators have used to specifically inhibit the function of polyP.
Not surprisingly, ppk mutants are extremely sensitive to environmental stresses 
[13, 31, 32, 40, 41], and exhibit reduced motility, virulence, and biofilm produc-
tion [42]. ppk gene expression is regulated by σ38, a transcriptional regulator for 
late stationary phase genes [43] and polyP, in turn, amplifies its own synthesis by 
inducing transcription of the gene encoding σ38 (RpoS) [29, 41, 42]. In response 
to oxidative or heat stress, polyP synthesis is regulated at a transcriptional and/or 
post-translational level, as PPK synthesis and levels are altered by antisense RNA 
that target ppk mRNA transcripts [44] as well as transient inactivation of PPX by 
stress-sensitive regulators that allow polyP levels to remain high until normal condi-
tions are restored [45].
1.2 PolyP in eukaryotes
While polyP is found in eukaryotes from protists to mammalian cells [11], the 
mechanism of polyP synthesis remains largely unknown for most eukaryotic organ-
isms [1, 45], except for S. cerevisiae, where the vacuolar transporter chaperone 4 
(VTC4) synthesizes polyP from ATP and then transports the polymer into vacu-
oles [46, 47]. Vacuolar polyP maintains phosphate homeostasis by appropriating 
phosphate during growth in phosphate-rich conditions [46], and releases phosphate 
during the cell cycle to provide precursors for DNA replication [48].
There is no sequence or structural homology between the polyP-synthesizing 
enzymes PPK1, PPK2, or VTC4, and homologues have yet to be found in higher 
eukaryotes [1]. While phylogenetic analysis of the prokaryotic branch reveals 
no clear homologues of E. coli PPK in a large number of polyP-synthesizing spe-
cies [49], a few enzymes have been identified that use polyP as phosphate donor 
in reactions that can be reversed in the presence of excess substrate in vitro [49, 
50]. In the absence of a polyP-synthesizing enzyme, polyP may be synthesized 
by the mitochondrial proton-motive force [51], in a complex process involving 
intact mitochondrial membranes [52]. Decreased polyP production resulting from 
depolarization of the mitochondrial membrane [52, 53] suggests that this may be a 
spontaneous process that does not need catalysis. Alternatively, inositol phosphates 
have also been implicated in polyP metabolism, since polyP levels are diminished in 
cells lacking the enzyme that synthesizes highly phosphorylated inositols [54–57]. 
Similar to polyP synthesis, polyP-degrading enzymes, such as yeast PPX1, have 
been found in lower eukaryotes, while mammalian polyP-specific degradation 
enzymes are mostly uncharacterized. However, h-prune, which regulates cell 
migration, also acts as a exopolyphosphatase for short-chain polyP in vitro [58, 59].
Subcellular fractionation, immunofluorescent staining, and biochemical quanti-
fication reveal that polyP is localized to the nucleus, cell membrane, cytoplasm, and 
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intracellular organelles in mammalian cells. It is specifically enriched in nucleoli, 
acidocalcisomes (organelles rich in protons, calcium (Ca2+), and phosphorus), and 
mitochondria [11, 60–63]. In the brain, astrocytes secrete polyP, which is taken up 
by neurons, indicating both intra- and extracellular localization [64, 65]. Similar to 
vesicular packaging of ATP, astrocytes release polyP via exocytosis from vesicular 
nucleotide transporter (VNUT)-containing vesicles [65]. A putative G protein-
coupled receptor in D. discoideum mediates cell surface binding of extracellular 
polyP, which as a signaling molecule, elicits differential effects on cell-substratum 
adhesion and cytoskeletal F-actin levels [66].
Eukaryotic polyP levels are in the 20–100 μM range (expressed as Pi concentra-
tion), with chain lengths ranging from 50 to 800 Pi residues (rat tissues) [67], 
averaging ~80 Pi residues in human platelets [68] to 200 Pi residues in yeast [67], 
compared to bacterial polyP, which can range up to thousands of Pi units long [53]; 
however, up to 130 mm medium-sized polyP chains are stored in dense granules in 
thrombocytes and mast cells [62, 68, 69]. Brain tissue exhibits among the highest 
polyP levels (~100 µm), which drop with age and neurodegenerative disease [11, 
70–72], consistent with the role of polyP in stabilizing protein unfolding intermedi-
ates as amyloid-like precursors [32]. High levels of polyphosphate are also found 
in osteoblast matrix vesicles, the initial sites of bone mineral formation [73]. PolyP 
concentrations and chain lengths are dynamic, and depend on growth conditions of 
cells; for example in Plasmodia, polyP has an average chain length of 100 Pi, which 
is degraded to 10 Pi during sporulation [67].
Studies on the myriad roles of polyP in higher eukaryotes have recently gained 
momentum. PolyP is directly or indirectly involved in diverse cell processes, 
including control of cell bioenergetics, signal transduction, activation of the 
mitochondrial permeability transition pore (mPTP), Ca2+-signaling [74, 75], and 
maintenance of the mitochondrial membrane potential [74]. Associated with mPTP 
[74] and voltage-gated channels, polyP regulates neuronal excitability [76] and 
astroglial signaling [64]. About 39% of intracellular polyP pools in astrocytes are in 
mitochondria [77], playing a role in bioenergetics [52, 77] and Ca2+-handling [74, 
78, 79]. As a signaling molecule, polyP released from astrocytes can mediate the 
physiological response to brain hypoxia [65].
In addition to its role as a gliotransmitter in the autonomic nervous system [64], 
the polymer also interacts with a variety of proteins, such as mammalian target of 
rapamycin (mTOR), fibroblast growth factor (FGF)-2, TRPM8, integrin β1, and 
glycosomal and ribosomal proteins and enzymes, consequently modulating cell 
survival and cell growth [80–86]. A fascinating finding of several recent studies is 
that polyP can covalently and non-enzymatically modify a small number of specific 
proteins in yeast [81] and humans containing lysine residues located in poly-acidic, 
serine, and lysine-rich (PASK) motifs, some of which are involved in ribosome 
biogenesis [87].
PolyP is involved in mTOR signaling, cell proliferation, and apoptosis [74, 
80], and stimulates the mTOR pathway [80] at concentrations normally found in 
mammalian cells (0.15–1.5 mM); [11], suggesting a role for the polymer in mam-
malian cell proliferation. By promoting release of translation initiation factor 
eIF4E, mTOR stimulates initiation of translation, particularly proteins involved in 
cell growth and proliferation. PolyP also enhances the mitogenic activity of FGF-2 
by promoting its binding to cell surface receptors [83]. PolyP appears to regulate 
apoptosis by inducing activation of caspase-3 in human plasma cells [88]. This 
polyanion also chelates metals, such as manganese and cadmium, blocking metal-
induced cell damage [89, 90].
Other roles for polyP in mammalian cells include coagulation via activation of 
blood clotting factor XII [69], inflammation [91] as well as Ca2+ chelation for bone 
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mineralization and osteogenic differentiation [92]. The polymer also contributes to 
pro-inflammatory responses upon release from mast cells [62]. Finally, serving as 
a stabilizing scaffold for protein-folding intermediates, polyP was recently shown 
to work as a protein-like chaperone protecting cells against stress-induced protein 
aggregation [93].
2.  The contribution of polyP to cell survival, proliferation, and motility 
involved in wound healing in skin keratinocytes
Inorganic polyP shows promise in different phases of wound healing, including 
hemostasis and re-epithelialization, as polyP is a normal component of different 
cells that play a role in this process, including platelets, dermal fibroblasts, and 
keratinocytes. The use of polyP as a therapeutic for acute and chronic wounding 
has begun to garner interest, in part because of experiments elucidating its role in 
wound healing [33], as well as in hemostasis [69, 94–99]. We have recently shown 
a role for polyP in the response to UV survival, cell motility, and wound healing 
[33]. Addition of exogenous polyP increased the rate of wound healing in standard 
scratch wound assays in vitro [33].
Whereas candidates for mammalian polyP metabolism have been shown to 
exhibit additional enzymatic activities [59], more specific polyphosphatases 
have been identified in lower eukaryotes including yeast, trypanosomes, and 
Dictyostelium. We therefore used exopolyphosphatase derived from S. cerevisiae 
(ScPPX1) to target intracellular polyP in human skin keratinocytes, an obvious 
choice for UV resistance, motility, and wound healing. The functions of polyP in the 
response of keratinocytes to UVB or wounding was studied by expressing ScPPX1, 
which selectively breaks down endogenous inorganic polyP, and not phosphopro-
teins, DNA, RNA, or nucleotide mono-, di-, or triphosphates [6]. Cells depleted of 
intracellular polyP by ScPPX1 expression exhibited increased sensitivity to UVB via 
enhanced apoptosis, and impaired wound healing [33]. Human keratinocytes stably 
expressing constitutive HisPPX1 or tetracycline (Tet)-inducible HisPPX1 were used 
to deplete cells of endogenous polyP, and study its role in wound healing assays 
performed on confluent monolayers, mimicking cell re-epithelialization during 
wound healing in vivo. RT-PCR and immunoblot analysis confirmed PPX1 expres-
sion in stable HisPPX1-expressing cells or in the presence of Tet (Figure 1B and C). 
Scratch gaps demonstrate marked attenuation of wound healing following constitu-
tive HisPPX1 or Tet-induced expression (Figure 1D and E).
Since keratinocyte proliferation and migration are crucial to re-epithelialization 
during wound healing, the contribution of polyP to cell growth and motility 
involved in wound healing was next determined. Vector control cells exhibited 
significantly higher rates of cell growth as well as BrdU incorporation into newly 
synthesized DNA in cells at the wound edge, compared with polyP-depleted 
HisPPX1-expressing cells (Figure 2). Further, real time monitoring and measure-
ment of cell motility performed in an xCelligence impedance-based system revealed 
significant decreases in cell motility in polyP-depleted keratinocytes (Figure 3). 
These results demonstrate that polyP depletion by either constitutive or inducible 
expression of PPX1 retards the rate of wound healing in human skin keratinocytes, 
by decreasing cell proliferation and motility. To determine if the loss of endogenous 
polyP can be supplemented with exogenous extracellular polyP, ScPPX1-expressing 
cells were grown in the presence of different concentrations of polyP, or with polyP-
rich platelet lysate (next section). Exogenously added polyP was found to accelerate 
wound healing in human keratinocytes in polyP dose-response experiments on 
confluent monolayers of keratinocytes subjected to scratch wound healing assays 
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Figure 3. 
Real-time monitoring and measurement of cell motility was performed in an xCelligence impedance-based 
system. Total number of cells attached to the bottom chamber were measured every 15 min over 24 hours, and 
are shown as technical duplicates, with assays repeated twice (left). Percentage of cell migration at the 24-hour 
time-point based on 100,000 cells plated at the top chamber (right; modified with permission from [33]).
Figure 2. 
Constitutive PPX1 expression decreases growth rate of keratinocytes. Viable cell counts were performed over 
11 days, and growth curves plotted for HisPPX1-expressing cells compared to vector cells (top). HisPPX1 and 
vector controls were subjected to scratch assays and proliferation was measured by in situ BrdU incorporation in 
cells at the wound edge (middle and bottom; modified with permission from [33]).
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(Figure 4). Interestingly, both intracellular and extracellular polyP dose-depend-
ently increased the rate of wound healing in vitro.
3.  The use of polyP-containing PRP to promote wound healing in acute 
and chronic wounds, including burns
Wound healing is a highly coordinated process involving biochemical and 
physiological interplay of keratinocytes and fibroblasts to restore skin integrity. 
Platelets are components of blood responsible for blood clotting and wound heal-
ing. Although the importance of platelets in wound healing has been extensively 
studied, the bioactive substance playing a major role in skin re-epithelialization 
during wound healing is still unclear. PRP has been shown to support the survival 
and proliferation of human keratinocytes [100], and is currently used as thera-
peutic for both acute and chronic wounds (for review see [101]). Discovery of the 
release of growth factors triggered an interest in using PRP for wound healing, and 
platelet lysates have been examined as a replacement for using fetal bovine serum in 
cell cultures, which may contain contaminants such as prions, or elicit an unwanted 
immune response in patients. Platelet-rich lysates derived from platelets are a 
by-product of blood preparation, and are thus inexpensive. Most studies focused on 
lysates for mesenchymal stromal cell culture for cell therapy, in which platelets are 
activated by thrombin and CaCl2, or by freeze-thaw.
In recent years, PRP has gained traction in many different specialties including in 
dermatology where it is used to treat acne [102], scarring [103], and alopecia [104, 105], 
in regenerative medicine where it is used to treat acute and chronic injuries to bone and 
cartilage [106, 107], in orthopedics and sports medicine where it is used to treat rotator 
cuff tears, osteoarthritis of the knee, hamstring injuries, and Achilles tendinopathy 
[108–110], in dentistry where it is used during tooth extractions, periodontal surgery, 
and dental implant surgery [111, 112], and more recently in wound healing to promote 
enhanced healing [113–118]. PRP is an autologous blood product generated from 
multiple rounds of centrifugation that serve to concentrate the number of platelets in 
plasma. PRP contains high concentrations of growth factors such as platelet-derived 
growth factor (PDGF), epidermal growth factor (EGF), and transforming growth fac-
tor beta (TGFβ) compared to plasma and whole blood [119, 120]. It also contains higher 
levels of pro- and anti-inflammatory cytokines that promote enhanced healing. Lastly, 
PRP is known to contain inorganic polyP which is continually synthesized from ATP or 
GTP, and is degraded by cellular enzymes in bacteria and eukaryotes.
The role of polyP secreted by platelets and present in PRP on cell proliferation 
and wound healing was investigated in human HaCaT keratinocytes co-transduced 
Figure 4. 
PolyP dose-dependently accelerates wound healing in cultured human keratinocyte, using polyP at 1 μM (left) 
or 10 μM (right; modified with permission from [33]).
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with either ScPPX1 or vector control, along with DsRed or GFP, respectively, as 
fluorescent markers in order to visualize and track cells that have reduced or normal 
levels of polyP. Cells stably expressing fluorescent-tagged DsRed-PPX1 or GFP-
empty vector were incubated with platelet lysate (4%) supplemented with or with-
out exogenous pure polyP (1 μM). In both vector-GFP control and polyP-depleted 
PPX1-DsRed cells treated with polyP, platelet lysate, or platelet lysate + polyP, cell 
growth curves revealed a significant increase in cell proliferation compared to 
untreated controls (data to be published elsewhere). PolyP quantification in platelet 
lysates using a micromolar polyP assay kit showed that a 4% platelet lysate contains 
~8 μM polyP, which was within the range used for exogenously added polyP. This 
assay measures increase in fluorescence intensity (emission 550 nm, excitation 
415 nm) of a PPD dye upon binding to polyP.
Cell migration/scratch assays were performed on PPX1-DsRed or vector-GFP 
control keratinocytes to assess the effects on wound healing and cell motility. 
Fluorescent pictures were taken at 10 min intervals for 36 hours using an EVOS 
FL time-lapse imaging system, and gap closure was quantified by Image J. In both 
GFP-vector cells and PPX1-expressing cells, the rate of wound closure in the scratch 
assays were significantly increased when cells were incubated either with platelet 
lysate alone, polyP alone, or both (data to be published elsewhere). These results 
together indicate that exogenous polyP, delivered either purified or from platelet-
enriched plasma, can accelerate wound healing.
To assess whether the increased rate of wound healing is attributable to polyP in 
platelet lysates, specific polyP inhibitors (polyP-binding protein PPXbd or UHRA-
9, a kind gift from Dr. James Morrissey) were utilized in wound healing assays. 
PPXbd, a recombinant polyP-binding domain of E. coli exopolyphosphatase, binds 
to platelet-derived polyP and blocks FXI activation, thrombin and fibrin genera-
tion, and consequently, inhibiting polyP procoagulant activity [99]. Interestingly, 
the enhanced rates of wound healing in vector control or polyP-depleted ScPPX-
expressing cells induced by supplementation with exogenous extracellular polyP 
from pure polyP or in platelet lysates, was completely reversed by addition of 
the polyP inhibitors PPXbd or UHRA-9 (data to be published elsewhere). PolyP 
secreted by platelets and present in platelet lysate or PRP may therefore play an 
essential role in re-epithelialization during wound healing.
3.1 Chronic wounds
The acceleration of wound healing is of paramount importance in the setting 
of acute and chronic wounds, as well as burn wounds. Open chronic wounds are a 
significant cause of additional morbidity in patient populations that already have a 
plethora of comorbidities [121]. Significant improvements in complete healing were 
reported in chronic wounds treated with PRP compared to no topical treatments in 
a 2011 systematic review and meta-analysis on the use of PRP in acute and chronic 
wounds [101]. Another review of PubMed and Cochrane databases found significant 
benefit of PRP for diabetic chronic wounds, specifically in wounds unresponsive to 
standard of care treatment options [113]. A third systematic review of nine random-
ized controlled clinical trials (RCT) suggested that well-designed high-powered 
RCTs are needed to demonstrate increased wound healing with PRP treatment [122].
Treatment of 56 patients with diabetic foot ulcers with twice weekly applications 
of PRP resulted in complete healing in 86% of patients in the treated groups vs. only 
68% in the control group [123]. Animal models using exosomes derived from PRP 
for full thickness skin wounds in a diabetic rat model also showed increased healing, 
as well as increased fibroblast proliferation and migration [124]. Platelet-rich fibrin 
also improved diabetic animal skin wound healing [125]. Overall, while there is no 
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consensus on this treatment modality in chronic wounds, it is becoming widely used, 
and many trials seek to understand its potential beneficial effects. Improvements in 
open wound area have been shown in a number of animal and clinical studies.
3.2 Acute wounds
Meta-analysis of rodent and non-rodent studies using a systematic review 
conducted under preferred reported items for systematic review of interventions 
(PRISMA) guidelines indicated that the treatment of wounds with PRP resulted in 
reduction of open wound area [126]. In addition to its role in wound healing, PRP 
reduced complications such as wound infection, exudate (mass of cells and fluid 
that seeps out of a wound), drainage, and hematoma formation [101]. PRP and PRP 
with keratinocyte and fibroblast cells were shown to increase re-epithelialization 
at 7–14 days post-injury in mouse models, compared to non-treated controls [127]. 
In full thickness porcine wounds treated with the secreted proteins of PRP, wound 
re-epithelialization and collagen deposition were significantly increased in treated 
animals vs. saline controls [128]. Thus, PRP may improve wound healing in acute 
surgical wounds by secreting growth factors that support local microenvironments 
that promotes healing [129]. PRP’s effectiveness has also been shown in bone grafting, 
cartilage regeneration, and non-cutaneous surgical procedures. The impact of PRP on 
normal and damaged (derived from chronic ulcers or irradiated) fibroblasts have been 
described [130]. In addition, despite the lack of reproducibility of platelet concentra-
tions due to differences in manufacturer-specific protocols for PRP preparation and 
differences in treatment methodologies, PRP has been shown to affect fibroblast 
proliferation and migration in a number of in vitro studies. As with chronic wounds, it 
is unclear why some studies, but not others, show a beneficial effect of PRP treatment.
3.3 Burns
PRP has been used as a topical treatment to accelerate wound healing in burn 
wounds, however, like in chronic and acute wounds, its use is still debated due to 
conflicting results [114]. Some papers recommend its use [115, 117, 118, 131–135], 
while others have shown non-significant changes in outcomes after treatment 
with PRP, and advise caution in using it in a wide-spread manner [114, 136–138]. 
A review of PRP for burns concluded that PRP may be useful in regeneration of 
dermal structures, increasing graft-take, and increasing re-epithelialization, but 
recommended further research on characterization of the mechanisms by which 
PRP can improve burn wound healing, donor site healing, and scar outcomes [139].
The use of side-by-side treatment of a split thickness skin graft (STSG) donor 
site with standard treatment or with PRP showed complete re-epithelialization in 
the PRP-treated side at day 11 vs. day 13 for the control. Histological samples taken 
from these healing wounds, and by H and E staining revealed increased epidermal 
thickness in PRP-treated wounds, as well as a significant increase in the number 
of blood vessels. After platelet concentrate in conjunction with STSG was used 
for deep burns, monitoring of viscoelastic properties of the resultant scars over 
12 months revealed that the skin’s return to normal viscoelastic properties was 
accelerated in burns treated with PRP compared to controls [133]. Compared to 
historic institutional standard of care controls, treatment of deep partial thick-
ness (DPT) burns using PRP applied with the autograft during skin grafting, pain 
scores, inflammation, pruritis (itchiness), cosmesis of the scar, and perfusion all 
showed improved outcomes [135].
Animal models of burn injury in rats treated with topical PRP or control showed 
that PRP treatment resulted in increased hydroxyproline, decreased inflammatory 
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cells infiltration, but no difference in fibroblast collagen production or angiogen-
esis [134]. In a rat animal model of DPT burns, PRP was effective in increasing % 
wound closure, but showed little effectiveness in the full thickness injury group. 
PRP treatment resulted in increased neo-epidermal thickness at day 21, as well 
as decreases in CD31, 68, and 163, TGFβ1, MMP2, and MPO+ cells indicating an 
increased resolution of inflammation [118]. PRP injection in burn wound scars 
in a rat animal model of burn injury also showed pain-associated markers to be 
decreased with treatment [132]. While positive healing was observed in most mod-
els, in a recent study using a swine model of burn, tangential excision, and grafting 
with or without PRP, PRP showed similar effect on re-epithelialization and scarring 
in full thickness wounds compared to control wounds [136].
In a randomized clinical trial from 2018, 27 patients with DPT burns that did not 
get autografted were treated with lyophilized PRP powder, and showed a signifi-
cant increased percent wound closure at 3 weeks in the treated group compared to 
control. Additionally, the infection rate in the PRP group was 26%, while 33% of 
control patients had postoperative infections [115]. PRP’s concentrated secretion 
of growth factors may include basic fibroblast growth factor, epidermal growth 
factor, platelet-derived growth factor (PDGF), insulin-like growth factor, trans-
forming growth factor β (TGFβ1), and vascular endothelial growth factor (VEGF) 
as probable mechanisms by which it can accelerate healing [139]. However, quan-
tification of growth factors TGFβ1, PDGF-AA, and VEGF in a cohort of five burn 
patients compared to five healthy volunteers showed comparable levels of growth 
factors in the PRP from burn patients and health volunteers. Thus, there may be an 
additional factor in PRP that is possibly altered in burn patients (or patients with 
other pathologies such as diabetes or other conditions that would lead them to have 
surgical procedures yielding acute wounds) that may contribute to its success in 
treating some wounds and failure in others. Due to the effect burns have on the 
pathophysiology of blood coagulopathy [140–142] and capillary endotheliopathy 
[143, 144] after injury, it is reasonable to assume that platelets from burn patients 
may have differing levels of polyP. Associating this data with what is known about 
polyP, its ubiquitous presence in all prokaryotic and eukaryotic organisms, and its 
role in the response to cellular stress, it was hypothesized that polyP may contribute 
to wound healing.
4.  PolyP and polyP-containing platelet rich plasma accelerates 
re-epithelialization in vitro and in vivo
A HaCaT keratinocyte polyP-depleted cell line and vector control was used in 
growth curves and scratch assays to evaluate polyP, platelet lysate, or combined 
treatment to accelerate wound healing in vitro. PolyP-containing PRP was also 
evaluated as a treatment in a splinted model of excisional wounding in vivo. 
Exogenous polyP was also spiked into PRP to assess its role. Treatment with 
the polyP-containing treatments increased cell growth and attenuated open 
wound area in vitro (p < 0.001). Addition of a polyP inhibitor abrogated these 
effects (p < 0.0001). PRP-treated wounds re-epithelialized faster compared 
to untreated wounds when analyzed at Days 3 and 5 (n = 6 wounds, p < 0.05). 
Re-epithelialization was further enhanced by exogenous polyP addition to PRP 
as evidenced by elongated epithelial tongues (Figure 5) in the low and high dose 
PRP + polyP treatment groups compared to PRP alone (n = 8 wounds, p < 0.05; 
data to be published elsewhere). Due to its autologous nature, PRP serves as a safe 
and efficacious option for accelerating wound healing, and may be enhanced by 
the exogenous addition of polyP.
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4.1 PRP-treated wounds heal faster than controls in vivo
PRP was generated based on a previously published protocol [145]. Briefly, whole 
blood was collected, and centrifuged to create platelet-poor plasma (PPP) and a pellet 
of platelets. PPP was then removed and the platelets were resuspended and activated 
with thrombin and calcium chloride (CaCl2) to form a “biobandage”-like gel. Whole 
blood, packed RBCS, and PRP were stained with Wright and Giemsa stains to confirm 
PRP platelet concentration. A murine model of full thickness excisional wound heal-
ing was used where 6 mm punch biopsies were created on dorsal flanks of C57BL/6 
mice [146, 147]. Wounds were splinted to encourage healing by re-epithelialization 
as opposed to contracture. They were subsequently treated with PRP, or no treatment 
was applied. Tegaderm dressing was applied and kept in place for 3 days. Pictures 
were taken at days 3, 4, 5, 6, or 7. By day 7, wounds were mostly closed.
In a second experiment, wounded mice were divided into four treatment groups: 
untreated, PRP only, PRP + 10 μM polyP (low dose) and PRP + 100 μM polyP (high 
dose). Doses of polyP were calculated by examining historical data from the litera-
ture on platelet levels, as well as polyP concentrations in platelets. The mean platelet 
count for C57BL/6 mice is 9.85 ± 1.40 × 1011 platelets/L, however, because there are no 
reliable reports of polyP concentrations per platelet in mice, human platelet counts 
and polyP concentrations were extrapolated for this experiment [148]. Human plate-
let concentrations range from 1.5 to 4.5 × 1011 platelets/L [149]. It is also known that 
platelets contain 0.74 ± 0.08 μmol polyP/1 × 1011 platelets [150]. Therefore, whole 
blood should contain between 1 and 3 μM polyP, and PRP, which contains at least 
3-fold higher levels of platelets compared to whole blood, should contain 3–9 μM of 
polyP. We added ~10 μM in the low dose group, and a 10× concentration compared to 
the low dose group for the high dose group (100 μM). Lyophilized polyP was recon-
stituted in dH2O to 1 M. PolyP took up 10% of the total treatment volume of PRP.
Treatments were applied on Day 0, and Tegaderm™ dressings stayed in place 
through day 3. On day 3 and 4, dressings were removed, and pictures were taken. 
On day 5, dressings were removed, pictures were taken, and wounds were excised 
Figure 5. 
Untreated or treated wounds were excised on day 5 and fixed in formalin, paraffin embedded, sectioned, and 
stained with H&E. Sections were imaged, and composited to create an image with areas of normal skin on both 
sides with the epithelial tongue (orange arrow) protruding from each side of normal skin. The epithelial gap is 
demarcated by the black arrow where no epithelium is present. Scale bar = 200 μm. Representative histology of 
untreated (A), PRP only treated (B), PRP + 10 μM polyP-treated wounds are shown. Epithelial tongue length 
was measured with Image J and quantified.
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with underlying fascia and were sewn into histological cassettes to retain wound 
orientation. These samples were then paraffin embedded and H&E stained. 
Sections were imaged, and epithelial tongue length was measured using Image 
J. Epithelial tongues were defined as new epithelium if there was no uninjured 
dermis underneath the epithelium.
Compared to whole blood, PRP contained a higher concentration of platelets 
(data to be published elsewhere). The splinted wound model was used to shift the 
healing towards re-epithelialization instead of the normal contraction observed in 
mice. PRP application was easily applied as a “bio-bandage” gel-like liquid (data to 
be published elsewhere). The 6 mm punch biopsies allowed for the creation of simi-
lar wound size between animal groups at day 0 (0.33 cm2 ± 0.13 vs. 0.39 ± 0.15 cm2, 
p = n.s.; data to be published elsewhere). At days 3 (0.09 ± 0.06 vs. 0.23 ± 0.13) and 
5 (0.12 ± 0.07 vs. 0.25 ± 0.12) PRP-treated wounds had significantly smaller open 
wound areas compared to control animals (n = 6, p < 0.05). At days 6 and 7, this 
difference leveled off.
4.2 Exogenous spiking of PRP with polyP further accelerates healing in vivo
To further investigate the potential role of polyP in PRP, wounds were treated 
with PRP or with PRP with low or high dose-spiked polyP. Untreated wounds were 
largely open by day 5, while PRP treated wounds were smaller and contained newly 
formed epithelium (data to be published elsewhere). Spiking with low or high dose 
polyP further stimulated epithelialization, and wounds were smaller with increas-
ing doses. By histomorphometric analysis, epithelial tongues can be seen by H&E 
staining. In untreated wounds, these tongues are small and shallow. PRP treatment 
results in a more proliferative epithelium that is thicker and longer than untreated 
samples. Spiking with low and high dose polyP creates longer epithelial tongues). 
Epithelial tongue measurement by Image J shows a significant decrease in tongue 
length in untreated and PRP only treated vs. PRP + high dose polyP (737.38 ± 121.21 
and 925.55 ± 214.17 vs. 1186.91 ± 255.06 μM, n = 8, p < 0.0001, p < 0.05). PRP + high 
dose polyP-treated wounds also had significantly longer epithelial tongues com-
pared to PRP + low dose polyP (n = 8, p < 0.05). PRP contains polyP at a concentra-
tion near 5 μM. The exogenous addition of polyP to the PRP promoted keratinocyte 
growth and proliferation, as is evidence by the increased epithelial tongue length 
with increasing doses of polyP administration.
5. Conclusion
PolyP plays key roles in essential biological processes in bacteria, and its increas-
ing importance in eukaryotes is becoming apparent, including its participation 
in blood coagulation and wound healing. Recent advances in measurement and 
localization of polyP, along with our growing understanding of polyP metabolism 
and its interaction with specific proteins allows us to begin to analyze mechanisms 
responsible for cell-specific roles of polyP. Our ability to regulate polyP in eukary-
otic cells opens possibilities for therapeutic intervention. Future work related to 
wound healing should be aimed at investigating the specific roles of intra- and 
extracellular polyP in keratinocytes, as well as the potential importance of polyP in 
other skin cells, including dermal fibroblasts, as these cells make up the majority of 
the skin. As polyP is also secreted by activated platelets and is important for normal 
blood clotting, the application of polyP-containing PRP as a biologic dressing may 
positively contribute to wound healing. We have completed two clinical trials using 
platelet-rich plasma for wound healing, a phenomenon that may be explained by 
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the presence of polyP. PolyP levels and chain lengths should also be quantified in 
healthy and pathologic conditions in order to assess appropriate levels when treat-
ing acute or chronic wounds in the future.
Acknowledgements
Authors are grateful for the technical assistance of Sixian Song in the scratch gap 
assays, and Dr. James Morrissey (University of Michigan Medical School) for the 
generous gift of polyP, and its inhibitors PPXbd and UHRA-9, used in their studies. 
This work was partially supported by the NIH STTR grant 1R41ES026908 (to DSR), 
and the office of the Dean of Research, Georgetown University School of Medicine.
Conflict of interest
The authors have no conflicts of interest to declare.
Author details
Cynthia M. Simbulan-Rosenthal1, Bonnie C. Carney1,2, Anirudh Gaur1, 
Manish Moghe1, Elliott Crooke1, Lauren T. Moffatt1,2, Jeffrey W. Shupp1,2,3,4  
and Dean S. Rosenthal1*
1 Department of Biochemistry and Molecular and Cellular Biology,  
Georgetown University School of Medicine, Washington, DC, USA
2 Firefighters’ Burn and Surgical Research Laboratory, MedStar Health Research 
Institute, Washington, DC, USA
3 The Burn Center, Department of Surgery, MedStar Washington Hospital Center, 
Washington, DC, USA
4 Department of Surgery, Georgetown University School of Medicine, 
Washington, DC, USA
*Address all correspondence to: rosenthd@georgetown.edu
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
14
Biological Role of Phosphorus
References
[1] Rao NN, Gomez-Garcia MR, 
Kornberg A. Inorganic polyphosphate: 
Essential for growth and survival. 
Annual Review of Biochemistry. 
2009;78:605-647. DOI: 10.1146/annurev.
biochem.77.083007.093039
[2] Brown MR, Kornberg A. The long 
and short of it: Polyphosphate PPK 
and bacterial survival. Trends in 
Biochemical Sciences. 2008;33(6):284-
290. DOI: 10.1016/j.tibs.2008.04.005
[3] Gomez-Garcia MR, Kornberg A.  
Formation of an actin-like filament 
concurrent with the enzymatic 
synthesis of inorganic polyphosphate. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2004;101(45):15876-15880. 
DOI: 10.1073/pnas.0406923101
[4] Zhang H, Ishige K, Kornberg A. A 
polyphosphate kinase (PPK2) widely 
conserved in bacteria. Proceedings 
of the National Academy of Sciences 
of the United States of America. 
2002;99(26):16678-16683. DOI: 
10.1073/pnas.262655199
[5] Akiyama M, Crooke E, Kornberg A.  
An exopolyphosphatase of Escherichia 
coli. The enzyme and its ppx gene 
in a polyphosphate operon. The 
Journal of Biological Chemistry. 
1993;268(1):633-639
[6] Wurst H, Kornberg A. A 
soluble exopolyphosphatase of 
Saccharomyces cerevisiae. Purification 
and characterization. The 
Journal of Biological Chemistry. 
1994;269(15):10996-11001
[7] Wurst H, Shiba T, Kornberg A. The 
gene for a major exopolyphosphatase 
of Saccharomyces cerevisiae. Journal of 
Bacteriology. 1995;177(4):898-906
[8] Lichko LP, Kulakovskaya TV, Kulaev 
IS. Inorganic polyphosphate and 
exopolyphosphatase in the nuclei of 
Saccharomyces cerevisiae: Dependence 
on the growth phase and inactivation 
of the PPX1 and PPN1 genes. Yeast. 
2006;23(10):735-740. DOI: 10.1002/
yea.1391
[9] Sethuraman A, Rao NN, Kornberg A.  
The endopolyphosphatase gene: 
Essential in Saccharomyces cerevisiae. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2001;98(15):8542-8547. DOI: 
10.1073/pnas.151269398
[10] Luginbuehl E et al. The 
exopolyphosphatase TbrPPX1 of 
Trypanosoma brucei. BMC Microbiology. 
2011;11:4. DOI: 10.1186/1471-2180-11-4
[11] Kumble KD, Kornberg A. Inorganic 
polyphosphate in mammalian cells 
and tissues. The Journal of Biological 
Chemistry. 1995;270(11):5818-5822
[12] Rao NN, Kornberg A. Inorganic 
polyphosphate regulates responses 
of Escherichia coli to nutritional 
stringencies, environmental stresses 
and survival in the stationary phase. 
Progress in Molecular and Subcellular 
Biology. 1999;23:183-195
[13] Crooke E et al. Genetically altered 
levels of inorganic polyphosphate in 
Escherichia coli. The Journal of Biological 
Chemistry. 1994;269(9):6290-6295
[14] Alcantara C et al. Accumulation 
of polyphosphate in Lactobacillus 
spp. and its involvement in stress 
resistance. Applied and Environmental 
Microbiology. 2014;80(5):1650-1659. 
DOI: 10.1128/AEM.03997-13
[15] Nikel PI et al. Accumulation of 
inorganic polyphosphate enables stress 
endurance and catalytic vigour in 
Pseudomonas putida KT2440. Microbial 
Cell Factories. 2013;12:50. DOI: 
10.1186/1475-2859-12-50
15
Inorganic Polyphosphates Are Important for Cell Survival and Motility of Human Skin…
DOI: http://dx.doi.org/10.5772/intechopen.87183
[16] Singh R et al. Polyphosphate 
deficiency in Mycobacterium tuberculosis 
is associated with enhanced drug 
susceptibility and impaired growth in 
Guinea pigs. Journal of Bacteriology. 
2013;195(12):2839-2851. DOI: 10.1128/
JB.00038-13
[17] Rao NN, Liu S, Kornberg A.  
Inorganic polyphosphate in Escherichia 
coli: The phosphate regulon and 
the stringent response. Journal of 
Bacteriology. 1998;180(8):2186-2193
[18] Rao NN, Kornberg A. Inorganic 
polyphosphate supports resistance 
and survival of stationary-phase 
Escherichia coli. Journal of Bacteriology. 
1996;178(5):1394-1400
[19] Rashid MH, Kornberg A. Inorganic 
polyphosphate is needed for swimming, 
swarming, and twitching motilities of 
Pseudomonas aeruginosa. Proceedings 
of the National Academy of Sciences 
of the United States of America. 
2000;97(9):4885-4890. DOI: 10.1073/
pnas.060030097
[20] Rashid MH, Rao NN, Kornberg 
A. Inorganic polyphosphate is 
required for motility of bacterial 
pathogens. Journal of Bacteriology. 
2000;182(1):225-227
[21] Shi X, Rao NN, Kornberg A.  
Inorganic polyphosphate in Bacillus 
cereus: Motility, biofilm formation, and 
sporulation. Proceedings of the National 
Academy of Sciences of the United 
States of America. 2004;101(49):17061-
17065. DOI: 10.1073/pnas.0407787101
[22] Rashid MH et al. Polyphosphate 
kinase is essential for biofilm 
development, quorum sensing, and 
virulence of Pseudomonas aeruginosa. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2000;97(17):9636-9641. DOI: 
10.1073/pnas.170283397
[23] Kim KS et al. Inorganic 
polyphosphate is essential for long-term 
survival and virulence factors in Shigella 
and Salmonella spp. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
2002;99(11):7675-7680. DOI: 10.1073/
pnas.112210499
[24] Ahn K, Kornberg A. Polyphosphate 
kinase from Escherichia coli. Purification 
and demonstration of a phosphoenzyme 
intermediate. The Journal of Biological 
Chemistry. 1990;265(20):11734-11739
[25] Ishige K, Zhang H, Kornberg A.  
Polyphosphate kinase (PPK2), a potent, 
polyphosphate-driven generator of 
GTP. Proceedings of the National 
Academy of Sciences of the United 
States of America. 2002;99(26):16684-
16688. DOI: 10.1073/pnas.262655299
[26] Nocek B et al. Polyphosphate-
dependent synthesis of ATP and ADP 
by the family-2 polyphosphate kinases 
in bacteria. Proceedings of the National 
Academy of Sciences of the United States 
of America. 2008;105(46):17730-17735. 
DOI: 10.1073/pnas.0807563105
[27] Rudat AK et al. Mutations in 
Escherichia coli polyphosphate kinase 
that lead to dramatically increased 
in vivo polyphosphate levels. Journal of 
Bacteriology. 2018;200(6):pii: e00697-17. 
DOI: 10.1128/JB.00697-17
[28] Ault-Riche D et al. Novel assay 
reveals multiple pathways regulating 
stress-induced accumulations of 
inorganic polyphosphate in Escherichia 
coli. Journal of Bacteriology. 
1998;180(7):1841-1847
[29] Shiba T et al. Inorganic 
polyphosphate and the induction 
of rpoS expression. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
1997;94(21):11210-11215
[30] Mullan A, Quinn JP, McGrath JW.  
Enhanced phosphate uptake and 
polyphosphate accumulation in 
Biological Role of Phosphorus
16
Burkholderia cepacia grown under low 
pH conditions. Microbial Ecology. 
2002;44(1):69-77. DOI: 10.1007/
s00248-002-3004-x
[31] Gray MJ et al. Polyphosphate is a 
primordial chaperone. Molecular Cell. 
2014;53(5):689-699. DOI: 10.1016/j.
molcel.2014.01.012
[32] Yoo NG et al. Polyphosphate 
stabilizes protein unfolding 
intermediates as soluble amyloid-like 
oligomers. Journal of Molecular Biology. 
2018;430(21):4195-4208. DOI: 10.1016/j.
jmb.2018.08.016
[33] Simbulan-Rosenthal CM et al. 
Inorganic polyphosphates are important 
for cell survival and motility of human 
skin keratinocytes. Experimental 
Dermatology. 2015;24(8):636-639. DOI: 
10.1111/exd.12729
[34] Werner TP, Amrhein N, 
Freimoser FM. Novel method for 
the quantification of inorganic 
polyphosphate (iPoP) in Saccharomyces 
cerevisiae shows dependence of iPoP 
content on the growth phase. Archives 
of Microbiology. 2005;184(2):129-136. 
DOI: 10.1007/s00203-005-0031-2
[35] Freimoser FM et al. Systematic 
screening of polyphosphate (poly P) 
levels in yeast mutant cells reveals 
strong interdependence with primary 
metabolism. Genome Biology. 
2006;7(11):R109. DOI: 10.1186/
gb-2006-7-11-r109
[36] Zakrzewska J, Zizic M, Zivic M. The 
effect of anoxia on PolyP content of 
Phycomyces blakesleeanus mycelium 
studied by 31P NMR spectroscopy. 
Annals of the New York Academy of 
Sciences. 2005;1048:482-486. DOI: 
10.1196/annals.1342.073
[37] Choi BK, Hercules DM, 
Houalla M. Characterization of 
polyphosphates by electrospray mass 
spectrometry. Analytical Chemistry. 
2000;72(20):5087-5091
[38] Comolli LR, Kundmann M, 
Downing KH. Characterization of 
intact subcellular bodies in whole 
bacteria by cryo-electron tomography 
and spectroscopic imaging. Journal of 
Microscopy. 2006;223(Pt 1):40-52. DOI: 
10.1111/j.1365-2818.2006.01597.x
[39] Saito K et al. Direct labeling of 
polyphosphate at the ultrastructural 
level in Saccharomyces cerevisiae by 
using the affinity of the polyphosphate 
binding domain of Escherichia 
coli exopolyphosphatase. Applied 
and Environmental Microbiology. 
2005;71(10):5692-5701. DOI: 10.1128/
AEM.71.10.5692-5701.2005
[40] Groitl B et al. Pseudomonas 
aeruginosa defense systems against 
microbicidal oxidants. Molecular 
Microbiology. 2017;106(3):335-350. 
DOI: 10.1111/mmi.13768
[41] Dahl JU et al. The anti-
inflammatory drug mesalamine targets 
bacterial polyphosphate accumulation. 
Nature Microbiology. 2017;2:16267. DOI: 
10.1038/nmicrobiol.2016.267
[42] Fraley CD et al. A polyphosphate 
kinase 1 (ppk1) mutant of Pseudomonas 
aeruginosa exhibits multiple 
ultrastructural and functional defects. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2007;104(9):3526-3531. DOI: 
10.1073/pnas.0609733104
[43] Maciag A et al. In vitro transcription 
profiling of the sigmaS subunit 
of bacterial RNA polymerase: 
Re-definition of the sigmaS regulon 
and identification of sigmaS-specific 
promoter sequence elements. Nucleic 
Acids Research. 2011;39(13):5338-5355. 
DOI: 10.1093/nar/gkr129
[44] Silby MW, Nicoll JS, Levy SB.  
Regulation of polyphosphate kinase 
production by antisense RNA in 
Pseudomonas fluorescens Pf0-1. Applied 
and Environmental Microbiology. 
17
Inorganic Polyphosphates Are Important for Cell Survival and Motility of Human Skin…
DOI: http://dx.doi.org/10.5772/intechopen.87183
2012;78(12):4533-4537. DOI: 10.1128/
AEM.07836-11
[45] Kuroda A, Kornberg A.  
Polyphosphate kinase as a nucleoside 
diphosphate kinase in Escherichia 
coli and Pseudomonas aeruginosa. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 1997;94(2):439-442
[46] Ogawa N, DeRisi J, Brown PO. New 
components of a system for phosphate 
accumulation and polyphosphate 
metabolism in Saccharomyces cerevisiae 
revealed by genomic expression 
analysis. Molecular Biology of the Cell. 
2000;11(12):4309-4321. DOI: 10.1091/
mbc.11.12.4309
[47] Hothorn M et al. Catalytic core 
of a membrane-associated eukaryotic 
polyphosphate polymerase. Science. 
2009;324(5926):513-516. DOI: 10.1126/
science.1168120
[48] Bru S et al. Polyphosphate is involved 
in cell cycle progression and genomic 
stability in Saccharomyces cerevisiae. 
Molecular Microbiology. 2016;101(3):367-
380. DOI: 10.1111/mmi.13396
[49] Wang L et al. Distribution patterns 
of polyphosphate metabolism pathway 
and its relationships with bacterial 
durability and virulence. Frontiers in 
Microbiology. 2018;9:782. DOI: 10.3389/
fmicb.2018.00782
[50] Nahalka J, Patoprsty V. Enzymatic 
synthesis of sialylation substrates 
powered by a novel polyphosphate 
kinase (PPK3). Organic & Biomolecular 
Chemistry. 2009;7(9):1778-1780. DOI: 
10.1039/b822549b
[51] Pestov NA, Kulakovskaya TV, 
Kulaev IS. Inorganic polyphosphate 
in mitochondria of Saccharomyces 
cerevisiae at phosphate limitation and 
phosphate excess. FEMS Yeast Research. 
2004;4(6):643-648. DOI: 10.1016/j.
femsyr.2003.12.008
[52] Pavlov E et al. Inorganic 
polyphosphate and energy 
metabolism in mammalian cells. 
The Journal of Biological Chemistry. 
2010;285(13):9420-9428. DOI: 10.1074/
jbc.M109.013011
[53] Kornberg A, Rao NN, Ault-Riche 
D. Inorganic polyphosphate: A molecule 
of many functions. Annual Review of 
Biochemistry. 1999;68:89-125. DOI: 
10.1146/annurev.biochem.68.1.89
[54] Lonetti A et al. Identification 
of an evolutionarily conserved 
family of inorganic polyphosphate 
endopolyphosphatases. The 
Journal of Biological Chemistry. 
2011;286(37):31966-31974. DOI: 
10.1074/jbc.M111.266320
[55] Cordeiro CD, Saiardi A, Docampo 
R. The inositol pyrophosphate 
synthesis pathway in Trypanosoma 
brucei is linked to polyphosphate 
synthesis in acidocalcisomes. Molecular 
Microbiology. 2017;106(2):319-333. 
DOI: 10.1111/mmi.13766
[56] Ghosh S et al. Inositol 
hexakisphosphate kinase 1 maintains 
hemostasis in mice by regulating 
platelet polyphosphate levels. Blood. 
2013;122(8):1478-1486. DOI: 10.1182/
blood-2013-01-481549
[57] Hou Q et al. Inhibition of IP6K1 
suppresses neutrophil-mediated 
pulmonary damage in bacterial 
pneumonia. Science Translational 
Medicine. 2018;10(435):pii: eaal4045. 
DOI: 10.1126/scitranslmed.aal4045
[58] Carotenuto M et al. H-prune 
through GSK-3beta interaction sustains 
canonical WNT/beta-catenin signaling 
enhancing cancer progression in 
NSCLC. Oncotarget. 2014;5(14):5736-
5749. DOI: 10.18632/oncotarget.2169
[59] Tammenkoski M et al. Human 
metastasis regulator protein H-prune 
is a short-chain exopolyphosphatase. 
Biological Role of Phosphorus
18
Biochemistry. 2008;47(36):9707-9713. 
DOI: 10.1021/bi8010847
[60] Aschar-Sobbi R et al. High 
sensitivity, quantitative measurements 
of polyphosphate using a new 
DAPI-based approach. Journal of 
Fluorescence. 2008;18(5):859-866. DOI: 
10.1007/s10895-008-0315-4
[61] Jimenez-Nunez MD et al. Myeloma 
cells contain high levels of inorganic 
polyphosphate which is associated with 
nucleolar transcription. Haematologica. 
2012;97(8):1264-1271. DOI: 10.3324/
haematol.2011.051409
[62] Moreno-Sanchez D et al. 
Polyphosphate is a novel pro-
inflammatory regulator of mast cells and is 
located in acidocalcisomes. The Journal of 
Biological Chemistry. 2012;287(34):28435-
28444. DOI: 10.1074/jbc.M112.385823
[63] Angelova PR et al. In situ investigation 
of mammalian inorganic polyphosphate 
localization using novel selective 
fluorescent probes JC-D7 and JC-D8. ACS 
Chemical Biology. 2014;9(9):2101-2110. 
DOI: 10.1021/cb5000696
[64] Holmstrom KM et al. Signalling 
properties of inorganic polyphosphate 
in the mammalian brain. Nature 
Communications. 2013;4:1362. DOI: 
10.1038/ncomms2364
[65] Angelova PR et al. Signal 
transduction in astrocytes: Localization 
and release of inorganic polyphosphate. 
Glia. 2018;66(10):2126-2136. DOI: 
10.1002/glia.23466
[66] Suess PM, Tang Y, Gomer RH.  
The putative G protein-coupled 
receptor GrlD mediates extracellular 
polyphosphate sensing in Dictyostelium 
discoideum. Molecular Biology of 
the Cell. 2019;30(9):1118-1128. DOI: 
10.1091/mbc.E18-10-0686
[67] Chen KY. Study of polyphosphate 
metabolism in intact cells by 
31-P nuclear magnetic resonance 
spectroscopy. Progress in Molecular and 
Subcellular Biology. 1999;23:253-273
[68] Ruiz FA et al. Human platelet 
dense granules contain polyphosphate 
and are similar to acidocalcisomes of 
bacteria and unicellular eukaryotes. 
The Journal of Biological Chemistry. 
2004;279(43):44250-44257. DOI: 
10.1074/jbc.M406261200
[69] Muller F et al. Platelet 
polyphosphates are proinflammatory 
and procoagulant mediators in vivo. 
Cell. 2009;139(6):1143-1156. DOI: 
10.1016/j.cell.2009.11.001
[70] Gabel NW, Thomas V. Evidence 
for the occurrence and distribution of 
inorganic polyphosphates in vertebrate 
tissues. Journal of Neurochemistry. 
1971;18(7):1229-1242
[71] Cremers CM et al. Polyphosphate: 
A conserved modifier of amyloidogenic 
processes. Molecular Cell. 
2016;63(5):768-780. DOI: 10.1016/j.
molcel.2016.07.016
[72] Lorenz B et al. Changes in 
metabolism of inorganic polyphosphate 
in rat tissues and human cells 
during development and apoptosis. 
Biochimica et Biophysica Acta. 
1997;1335(1-2):51-60. DOI: 10.1016/
S0304-4165(96)00121-3
[73] Li L et al. Long-chain 
polyphosphate in osteoblast matrix 
vesicles: Enrichment and inhibition 
of mineralization. Biochimica et 
Biophysica Acta: General Subjects. 
2019;1863(1):199-209. DOI: 10.1016/j.
bbagen.2018.10.003
[74] Abramov AY et al. Targeted 
polyphosphatase expression alters 
mitochondrial metabolism and 
inhibits calcium-dependent cell death. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2007;104(46):18091-18096. 
DOI: 10.1073/pnas.0708959104
19
Inorganic Polyphosphates Are Important for Cell Survival and Motility of Human Skin…
DOI: http://dx.doi.org/10.5772/intechopen.87183
[75] Seidlmayer LK et al. Inorganic 
polyphosphate is a potent activator 
of the mitochondrial permeability 
transition pore in cardiac myocytes. 
The Journal of General Physiology. 
2012;139(5):321-331. DOI: 10.1085/
jgp.201210788
[76] Stotz SC et al. Inorganic 
polyphosphate regulates neuronal 
excitability through modulation 
of voltage-gated channels. 
Molecular Brain. 2014;7(1):42. DOI: 
10.1186/1756-6606-7-42
[77] Angelova PR et al. Role of 
inorganic polyphosphate in mammalian 
cells: From signal transduction and 
mitochondrial metabolism to cell death. 
Biochemical Society Transactions. 
2016;44(1):40-45. DOI: 10.1042/
BST20150223
[78] Baev AY, Negoda A, Abramov AY.  
Modulation of mitochondrial ion 
transport by inorganic polyphosphate: 
Essential role in mitochondrial 
permeability transition pore. Journal 
of Bioenergetics and Biomembranes. 
2017;49(1):49-55. DOI: 10.1007/
s10863-016-9650-3
[79] Elustondo PA et al. Mitochondrial 
permeability transition pore induction 
is linked to formation of the complex of 
ATPase C-subunit, polyhydroxybutyrate 
and inorganic polyphosphate. Cell 
Death Discovery. 2016;2:16070. DOI: 
10.1038/cddiscovery.2016.70
[80] Wang L et al. Inorganic 
polyphosphate stimulates mammalian 
TOR, a kinase involved in the 
proliferation of mammary cancer cells. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2003;100(20):11249-11254. 
DOI: 10.1073/pnas.1534805100
[81] Azevedo C, Livermore T, Saiardi 
A. Protein polyphosphorylation 
of lysine residues by inorganic 
polyphosphate. Molecular Cell. 
2015;58(1):71-82. DOI: 10.1016/j.
molcel.2015.02.010
[82] Zakharian E et al. Inorganic 
polyphosphate modulates TRPM8 
channels. PLoS ONE. 2009;4(4):e5404. 
DOI: 10.1371/journal.pone.0005404
[83] Shiba T et al. Modulation of 
mitogenic activity of fibroblast growth 
factors by inorganic polyphosphate. 
The Journal of Biological Chemistry. 
2003;278(29):26788-26792. DOI: 
10.1074/jbc.M303468200
[84] Segawa S et al. Probiotic-derived 
polyphosphate enhances the epithelial 
barrier function and maintains 
intestinal homeostasis through 
integrin-p38 MAPK pathway. PLoS 
ONE. 2011;6(8):e23278. DOI: 10.1371/
journal.pone.0023278
[85] Negreiros RS et al. Inorganic 
polyphosphate interacts with 
nucleolar and glycosomal proteins 
in trypanosomatids. Molecular 
Microbiology. 2018;110(6):973-994. 
DOI: 10.1111/mmi.14131
[86] Azevedo C et al. Screening a protein 
Array with synthetic biotinylated 
inorganic polyphosphate to define 
the human PolyP-ome. ACS Chemical 
Biology. 2018;13(8):1958-1963. DOI: 
10.1021/acschembio.8b00357
[87] Bentley-DeSousa A et al. A 
screen for candidate targets of lysine 
polyphosphorylation uncovers a 
conserved network implicated in 
ribosome biogenesis. Cell Reports. 
2018;22(13):3427-3439. DOI: 10.1016/j.
celrep.2018.02.104
[88] Hernandez-Ruiz L et al. Inorganic 
polyphosphate and specific induction 
of apoptosis in human plasma cells. 
Haematologica. 2006;91(9):1180-1186
[89] Trilisenko L, Kulakovskaya E, 
Kulakovskaya T. The cadmium tolerance 
in Saccharomyces cerevisiae depends on 
inorganic polyphosphate. Journal of 
Biological Role of Phosphorus
20
Basic Microbiology. 2017;57(11):982-
986. DOI: 10.1002/jobm.201700257
[90] Andreeva N et al. Adaptation 
of Saccharomyces cerevisiae to toxic 
manganese concentration triggers changes 
in inorganic polyphosphates. FEMS Yeast 
Research. 2013;13(5):463-470. DOI: 
10.1111/1567-1364.12049
[91] Dinarvand P et al. Polyphosphate 
amplifies proinflammatory responses 
of nuclear proteins through interaction 
with receptor for advanced glycation 
end products and P2Y1 purinergic 
receptor. Blood. 2014;123(6):935-945. 
DOI: 10.1182/blood-2013-09-529602
[92] Tsutsumi K et al. Morphogenetic study 
on the maturation of osteoblastic cell as 
induced by inorganic polyphosphate. 
PLoS ONE. 2014;9(2):e86834. DOI: 
10.1371/journal.pone.0086834
[93] Xie L, Jakob U. Inorganic 
polyphosphate, a multifunctional 
polyanionic protein scaffold. The 
Journal of Biological Chemistry. 
2019;294(6):2180-2190. DOI: 10.1074/
jbc.REV118.002808
[94] Choi SH, Smith SA, Morrissey 
JH. Polyphosphate is a cofactor for the 
activation of factor XI by thrombin. 
Blood. 2011;118(26):6963-6970. DOI: 
10.1182/blood-2011-07-368811
[95] Smith SA et al. Inhibition 
of polyphosphate as a novel 
strategy for preventing thrombosis 
and inflammation. Blood. 
2012;120(26):5103-5110. DOI: 10.1182/
blood-2012-07-444935
[96] Smith SA et al. Polyphosphate 
exerts differential effects on blood 
clotting, depending on polymer size. 
Blood. 2010;116(20):4353-4359. DOI: 
10.1182/blood-2010-01-266791
[97] Smith SA, Morrissey JH.  
Polyphosphate: A new player in the 
field of hemostasis. Current Opinion in 
Hematology. 2014;21(5):388-394. DOI: 
10.1097/MOH.0000000000000069
[98] Szymusiak M et al. Colloidal 
confinement of polyphosphate on 
gold nanoparticles robustly activates 
the contact pathway of blood 
coagulation. Bioconjugate Chemistry. 
2016;27(1):102-109. DOI: 10.1021/acs.
bioconjchem.5b00524
[99] Zhu S et al. FXIa and platelet 
polyphosphate as therapeutic targets 
during human blood clotting on 
collagen/tissue factor surfaces under 
flow. Blood. 2015;126(12):1494-1502. 
DOI: 10.1182/blood-2015-04-641472
[100] Baik SY et al. Effects of platelet 
lysate preparations on the proliferation 
of HaCaT cells. Annals of Laboratory 
Medicine. 2014;34(1):43-50. DOI: 
10.3343/alm.2014.34.1.43
[101] Carter MJ, Fylling CP, Parnell 
LK. Use of platelet rich plasma gel on 
wound healing: A systematic review and 
meta-analysis. Eplasty. 2011;11:e38
[102] Porwal S, Chahar YS, Singh 
PK. A comparative study of combined 
dermaroller and platelet-rich plasma 
versus dermaroller alone in acne scars 
and assessment of quality of life before 
and after treatment. Indian Journal of 
Dermatology. 2018;63(5):403-408. DOI: 
10.4103/ijd.IJD_118_17
[103] Alser OH, Goutos I. The evidence 
behind the use of platelet-rich plasma 
(PRP) in scar management: A literature 
review. Scars, Burns & Healing. 
2018;4:2059513118808773. DOI: 
10.1177/2059513118808773
[104] Garg S, Manchanda S. Platelet-
rich plasma-an 'Elixir' for treatment of 
alopecia: Personal experience on 117 
patients with review of literature. Stem 
Cell Investigation. 2017;4:64. DOI: 
10.21037/sci.2017.06.07
[105] Alves R, Grimalt R. Double-
blind, placebo-controlled pilot study 
21
Inorganic Polyphosphates Are Important for Cell Survival and Motility of Human Skin…
DOI: http://dx.doi.org/10.5772/intechopen.87183
on the use of platelet-rich plasma in 
women with female androgenetic 
alopecia. Dermatologic Surgery. 
2018;44(1):132-133. DOI: 10.1097/
DSS.0000000000001197
[106] Liou JJ et al. Effect of platelet-rich 
plasma on chondrogenic differentiation 
of adipose- and bone marrow-derived 
mesenchymal stem cells. Tissue 
Engineering. Part A. 2018;24(19-
20):1432-1443. DOI: 10.1089/ten.
tea.2018.0065
[107] Xie X, Zhang C, Tuan RS. Biology 
of platelet-rich plasma and its clinical 
application in cartilage repair. Arthritis 
Research & Therapy. 2014;16(1):204. 
DOI: 10.1186/ar4493
[108] Chiavaras MM et al. IMpact of 
Platelet Rich plasma OVer alternative 
therapies in patients with lateral 
epicondylitis (IMPROVE): Protocol for 
a multicenter randomized controlled 
study: A multicenter, randomized trial 
comparing autologous platelet-rich 
plasma, autologous whole blood, dry 
needle tendon fenestration, and physical 
therapy exercises alone on pain and 
quality of life in patients with lateral 
epicondylitis. Academic Radiology. 
2014;21(9):1144-1155. DOI: 10.1016/j.
acra.2014.05.003
[109] Hussain N, Johal H, Bhandari 
M. An evidence-based evaluation 
on the use of platelet rich plasma in 
orthopedics: A review of the literature. 
SICOT J. 2017;3:57. DOI: 10.1051/
sicotj/2017036
[110] Bansal H et al. Intra-articular 
injection in the knee of adipose 
derived stromal cells (stromal vascular 
fraction) and platelet rich plasma for 
osteoarthritis. Journal of Translational 
Medicine. 2017;15(1):141. DOI: 10.1186/
s12967-017-1242-4
[111] Huang Y et al. Platelet-rich plasma 
for regeneration of neural feedback 
pathways around dental implants: A 
concise review and outlook on future 
possibilities. International Journal 
of Oral Science. 2017;9(1):1-9. DOI: 
10.1038/ijos.2017.1
[112] Agrawal AA. Evolution, current 
status and advances in application of 
platelet concentrate in periodontics 
and implantology. World Journal of 
Clinical Cases. 2017;5(5):159-171. DOI: 
10.12998/wjcc.v5.i5.159
[113] Picard F et al. The growing 
evidence for the use of platelet-rich 
plasma on diabetic chronic wounds: 
A review and a proposal for a new 
standard care. Wound Repair and 
Regeneration. 2015;23(5):638-643. DOI: 
10.1111/wrr.12317
[114] Picard F et al. Should we use 
platelet-rich plasma as an adjunct 
therapy to treat "acute wounds," 
"burns," and "laser therapies": A 
review and a proposal of a quality 
criteria checklist for further studies. 
Wound Repair and Regeneration. 
2015;23(2):163-170. DOI: 10.1111/
wrr.12266
[115] Yeung CY et al. Efficacy of 
lyophilised platelet-rich plasma 
powder on healing rate in patients with 
deep second degree burn injury: A 
prospective double-blind randomized 
clinical trial. Annals of Plastic Surgery. 
2018;80(2S Suppl 1):S66-S69. DOI: 
10.1097/SAP.0000000000001328
[116] Hara T et al. Platelet-rich plasma 
stimulates human dermal fibroblast 
proliferation via a Ras-dependent 
extracellular signal-regulated kinase 1/2 
pathway. Journal of Artificial Organs. 
2016;19(4):372-377. DOI: 10.1007/
s10047-016-0913-x
[117] Kakudo N et al. Platelet-rich 
plasma promotes epithelialization and 
angiogenesis in a splitthickness skin 
graft donor site. Medical Molecular 
Morphology. 2011;44(4):233-236. DOI: 
10.1007/s00795-010-0532-1
Biological Role of Phosphorus
22
[118] Venter NG et al. Use of platelet-rich 
plasma in deep second- and third-
degree burns. Burns. 2016;42(4):807-
814. DOI: 10.1016/j.burns.2016.01.002
[119] Alves R, Grimalt R. A review 
of platelet-rich plasma: History, 
biology, mechanism of action, and 
classification. Skin Appendage 
Disorders. 2018;4(1):18-24. DOI: 
10.1159/000477353
[120] Arnoczky SP, Sheibani-Rad S. The 
basic science of platelet-rich plasma 
(PRP): What clinicians need to know. 
Sports Medicine and Arthroscopy 
Review. 2013;21(4):180-185. DOI: 
10.1097/JSA.0b013e3182999712
[121] Martinengo L et al. Prevalence 
of chronic wounds in the general 
population: Systematic review and 
meta-analysis of observational studies. 
Annals of Epidemiology. 2019;29:8-15. 
DOI: 10.1016/j.annepidem.2018.10.005
[122] Brick N. Autologous platelet-rich 
plasma for treating chronic wounds. 
The American Journal of Nursing. 
2013;113(8):54. DOI: 10.1097/01.
NAJ.0000432965.18634.85
[123] Ahmed M et al. Platelet-rich 
plasma for the treatment of clean 
diabetic foot ulcers. Annals of Vascular 
Surgery. 2017;38:206-211. DOI: 
10.1016/j.avsg.2016.04.023
[124] Guo SC et al. Exosomes derived 
from platelet-rich plasma promote the 
re-epithelization of chronic cutaneous 
wounds via activation of YAP in a 
diabetic rat model. Theranostics. 
2017;7(1):81-96. DOI: 10.7150/thno.16803
[125] Ding Y et al. Platelet-rich fibrin 
accelerates skin wound healing in 
diabetic mice. Annals of Plastic Surgery. 
2017;79(3):e15-e19. DOI: 10.1097/
SAP.0000000000001091
[126] Tambella AM et al. Platelet-rich 
plasma to treat experimentally-induced 
skin wounds in animals: A systematic 
review and meta-analysis. PLoS ONE. 
2018;13(1):e0191093. DOI: 10.1371/
journal.pone.0191093
[127] Law JX et al. Platelet-rich plasma 
with keratinocytes and fibroblasts 
enhance healing of full-thickness 
wounds. Journal of Tissue Viability. 
2017;26(3):208-215. DOI: 10.1016/j.
jtv.2017.05.003
[128] Long DW et al. Controlled delivery 
of platelet-derived proteins enhances 
porcine wound healing. Journal of 
Controlled Release. 2017;253:73-81. 
DOI: 10.1016/j.jconrel.2017.03.021
[129] Fernandez-Moure JS et al. 
Platelet-rich plasma: A biomimetic 
approach to enhancement of surgical 
wound healing. The Journal of Surgical 
Research. 2017;207:33-44. DOI: 
10.1016/j.jss.2016.08.063
[130] Devereaux J et al. Effects of 
platelet-rich plasma and platelet-poor 
plasma on human dermal fibroblasts. 
Maturitas. 2018;117:34-44. DOI: 
10.1016/j.maturitas.2018.09.001
[131] Maciel FB et al. Scanning electron 
microscopy and microbiological 
evaluation of equine burn wound repair 
after platelet-rich plasma gel treatment. 
Burns. 2012;38(7):1058-1065. DOI: 
10.1016/j.burns.2012.02.029
[132] Huang SH et al. Platelet-rich 
plasma injection in burn scar areas 
alleviates neuropathic scar pain. 
International Journal of Medical 
Sciences. 2018;15(3):238-247. DOI: 
10.7150/ijms.22563
[133] Klosova H et al. Objective evaluation 
of the effect of autologous platelet 
concentrate on post-operative scarring in 
deep burns. Burns. 2013;39(6):1263-1276. 
DOI: 10.1016/j.burns.2013.01.020
[134] Ozcelik U et al. Effect of 
topical platelet-rich plasma on burn 
healing after partial-thickness burn 
23
Inorganic Polyphosphates Are Important for Cell Survival and Motility of Human Skin…
DOI: http://dx.doi.org/10.5772/intechopen.87183
injury. Medical Science Monitor. 
2016;22:1903-1909
[135] Prochazka V et al. Addition of 
platelet concentrate to dermo-epidermal 
skin graft in deep burn trauma reduces 
scarring and need for revision surgeries. 
Biomedical Papers of the Medical Faculty 
of the University Palacky, Olomouc, 
Czech Republic. 2014;158(2):242-258. 
DOI: 10.5507/bp.2013.070
[136] Singer AJ et al. The effects of 
platelet rich plasma on healing of 
full thickness burns in swine. Burns. 
2018;44(6):1543-1550. DOI: 10.1016/j.
burns.2018.04.021
[137] Marck RE, Middelkoop E, 
Breederveld RS. Considerations on the 
use of platelet-rich plasma, specifically 
for burn treatment. Journal of Burn 
Care & Research. 2014;35(3):219-227. 
DOI: 10.1097/BCR.0b013e31829b334e
[138] Marck RE et al. The application of 
platelet-rich plasma in the treatment 
of deep dermal burns: A randomized, 
double-blind, intra-patient controlled 
study. Wound Repair and Regeneration. 
2016;24(4):712-720. DOI: 10.1111/
wrr.12443
[139] Pallua N, Wolter T, Markowicz 
M. Platelet-rich plasma in burns. 
Burns. 2010;36(1):4-8. DOI: 10.1016/j.
burns.2009.05.002
[140] Tejiram S et al. In-depth analysis 
of clotting dynamics in burn patients. 
The Journal of Surgical Research. 
2016;202(2):341-351. DOI: 10.1016/j.
jss.2016.01.006
[141] Shupp JW et al. Analysis of factor 
XIa, factor IXa and tissue factor activity 
in burn patients. Burns. 2018;44(2):436-
444. DOI: 10.1016/j.burns.2017.08.003
[142] Glas GJ, Levi M, Schultz MJ.  
Coagulopathy and its management 
in patients with severe burns. Journal 
of Thrombosis and Haemostasis. 
2016;14(5):865-874. DOI: 10.1111/
jth.13283
[143] Luker JN et al. Shedding of the 
endothelial glycocalyx is quantitatively 
proportional to burn injury severity. 
Annals of Burns and Fire Disasters. 
2018;31(1):17-22
[144] Vigiola Cruz M et al. Plasma 
ameliorates endothelial dysfunction 
in burn injury. The Journal of Surgical 
Research. 2019;233:459-466. DOI: 
10.1016/j.jss.2018.08.027
[145] Messora MR, Nagata MJH, 
Furlaneto FAC, Dornelles RCM, 
Bomfim SRM, Deliberador TM, et al. 
A standardized research protocol for 
plateletrich plasma (PRP) preparation 
in rats. Revista Brasileira De Saude 
Ocupacional. 2011;8(3):299-304
[146] Galiano RD et al. Quantitative and 
reproducible murine model of excisional 
wound healing. Wound Repair and 
Regeneration. 2004;12(4):485-492. DOI: 
10.1111/j.1067-1927.2004.12404.x
[147] Wang X et al. The mouse 
excisional wound splinting model, 
including applications for stem cell 
transplantation. Nature Protocols. 
2013;8(2):302-309. DOI: 10.1038/
nprot.2013.002
[148] Barrios M et al. Comparative 
hemostatic parameters in BALB/c, 
C57BL/6 and C3H/He mice. Thrombosis 
Research. 2009;124(3):338-343. DOI: 
10.1016/j.thromres.2008.11.001
[149] Giacomini A et al. Platelet count 
and parameters determined by the 
Bayer ADVIA 120 in reference subjects 
and patients. Clinical and Laboratory 
Haematology. 2001;23(3):181-186
[150] Morrissey JH, Choi SH, Smith 
SA. Polyphosphate: An ancient 
molecule that links platelets, 
coagulation, and inflammation. Blood. 
2012;119(25):5972-5979. DOI: 10.1182/
blood-2012-03-306605
